IB Options Brief: Thermo Fisher Scientific, Inc. (TMO)

Posted April 12th, 2012 by Caitlin Duffy in Unusual Activity

Near-Term Bullish Bets On The Rise At Thermo Fisher Scientific

TMO ñ Thermo Fisher Scientific, Inc.
Front month call buying on the provider of analytical technologies and laboratory products suggests at least one options player is positioning for the price of the underlying to extend gains in the near term. Shares in Thermo Fisher Scientific moved up sharply in the first three months of the 2012, climbing nearly 30.0% to $58.37 by the end of March. April showers washed away some of those gains, however, with the stock surrendering around 9.0% during the first two weeks of this month.

Todayís 2.6% pop in the price of the underlying to $54.72 saw a pickup in near-term bullish action on the stock. One or more traders snapped up calls on TMO, with around 1,090 contracts changing hands at the April $55 strike against open interest of 254 positions. Most of the calls appear to have been purchased for an average premium of $0.50 apiece, thus positioning buyers to profit should Thermo Fisherís shares increase another 1.4% to surpass the breakeven price of $55.50 by expiration next week. The Waltham, Massachusetts-based company is scheduled to report first-quarter earnings ahead of the opening bell on April 25th, the week following options expiration.

------------------------------------------------------------------------

Note: The material presented in this commentary is provided forinformational purposes only and is based upon information that isconsidered to be reliable. However, neither Interactive Brokers LLC norits affiliates warrant its completeness, accuracy or adequacy and itshould not be relied upon as such. Neither IB nor its affiliates areresponsible for any errors or omissions or for results obtained from theuse of this information. Past performance is not necessarily indicativeof future results.

This material is not intended as an offer or solicitation for thepurchase or sale of any security or other financial instrument.Securities or other financial instruments mentioned in this material arenot suitable for all investors. Any opinions expressed herein are givenin good faith, are subject to change without notice, and are onlycorrect as of the stated date of their issue. The information containedherein does not constitute advice on the tax consequences of making anyparticular investment decision. This material does not take into accountyour particular investment objectives, financial situations or needsand is not intended as a recommendation to you of any particularsecurities, financial instruments or strategies. Before investing, youshould consider whether it is suitable for your particular circumstancesand, as necessary, seek professional advice.